Brainstorm Cell Therapeutics Inc.
BCLI
$0.69
$0.00-0.29%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 29.00K | 5.00K | 824.00K | 1.64M | 187.00K |
| Total Receivables | 86.00K | 80.00K | 106.00K | 67.00K | 63.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 192.00K | 423.00K | 585.00K | 621.00K | 135.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 307.00K | 508.00K | 1.52M | 2.33M | 385.00K |
|
|
|||||
| Total Current Assets | 307.00K | 508.00K | 1.52M | 2.33M | 385.00K |
| Net Property, Plant & Equipment | 443.00K | 617.00K | 826.00K | 1.04M | 1.24M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00 | -- | -- | -- | 0.00 |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 272.00K | 255.00K | 225.00K | 204.00K | 206.00K |
| Total Assets | 1.02M | 1.38M | 2.57M | 3.57M | 1.83M |
|
|
|||||
| Total Accounts Payable | 7.07M | 6.42M | 6.00M | 6.80M | 6.08M |
| Total Accrued Expenses | 396.00K | 350.00K | 367.00K | 538.00K | 619.00K |
| Short-term Debt | 967.00K | 101.00K | 101.00K | 1.20M | 300.00K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 208.00K | 276.00K | 381.00K | 443.00K | 549.00K |
| Total Finance Division Other Current Liabilities | 2.37M | 1.88M | 1.68M | 1.92M | 1.43M |
| Total Other Current Liabilities | 2.37M | 1.88M | 1.68M | 1.92M | 1.43M |
| Total Current Liabilities | 11.01M | 9.02M | 8.53M | 10.90M | 8.98M |
|
|
|||||
| Total Current Liabilities | 11.01M | 9.02M | 8.53M | 10.90M | 8.98M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 967.00K | 101.00K | 101.00K | 1.20M | 300.00K |
| Capital Leases | -- | 50.00K | 95.00K | 127.00K | 171.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | 447.00K |
| Total Liabilities | 11.01M | 9.07M | 8.62M | 11.03M | 9.60M |
|
|
|||||
| Common Stock & APIC | 227.07M | 226.93M | 226.46M | 222.16M | 218.99M |
| Retained Earnings | -236.94M | -234.51M | -232.40M | -229.50M | -226.64M |
| Treasury Stock & Other | -116.00K | -116.00K | -116.00K | -116.00K | -116.00K |
| Total Common Equity | -9.99M | -7.69M | -6.06M | -7.46M | -7.76M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -9.99M | -7.69M | -6.06M | -7.46M | -7.76M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -9.99M | -7.69M | -6.06M | -7.46M | -7.76M |
|
|
|||||